These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 19464857)
1. Clostridium difficile ribotype 027 arrives in Hong Kong. Cheng VC; Yam WC; Chan JF; To KK; Ho PL; Yuen KY Int J Antimicrob Agents; 2009 Nov; 34(5):492-3. PubMed ID: 19464857 [No Abstract] [Full Text] [Related]
2. Laboratory-acquired clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers? Bouza E; Martin A; Van den Berg RJ; Kuijper EJ Clin Infect Dis; 2008 Dec; 47(11):1493-4. PubMed ID: 18986267 [No Abstract] [Full Text] [Related]
3. Clostridium difficile ribotype 027-associated disease in children with norovirus infection. Lukkarinen H; Eerola E; Ruohola A; Vainionpää R; Jalava J; Kotila S; Ruuskanen O Pediatr Infect Dis J; 2009 Sep; 28(9):847-8. PubMed ID: 19636284 [TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Kuijper EJ; van den Berg RJ; Debast S; Visser CE; Veenendaal D; Troelstra A; van der Kooi T; van den Hof S; Notermans DW Emerg Infect Dis; 2006 May; 12(5):827-30. PubMed ID: 16704846 [TBL] [Abstract][Full Text] [Related]
5. The epidemiology of Clostridium difficile in Scotland. Wiuff C; Brown DJ; Mather H; Banks AL; Eastaway A; Coia JE J Infect; 2011 Apr; 62(4):271-9. PubMed ID: 21300104 [TBL] [Abstract][Full Text] [Related]
6. Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007. Cheknis AK; Sambol SP; Davidson DM; Nagaro KJ; Mancini MC; Hidalgo-Arroyo GA; Brazier JS; Johnson S; Gerding DN Anaerobe; 2009 Dec; 15(6):230-3. PubMed ID: 19737618 [TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of clostridium difficile in a tertiary medical center in Israel: emergence of the polymerase chain reaction ribotype 027. Bishara J; Goldberg E; Madar-Shapiro L; Behor J; Samra Z Isr Med Assoc J; 2011 Jun; 13(6):338-41. PubMed ID: 21809729 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of toxin A-negative, toxin B-positive variant strains of Clostridium difficile isolated in Korea. Kim SJ; Kim H; Seo Y; Yong D; Jeong SH; Chong Y; Lee K Diagn Microbiol Infect Dis; 2010 Jun; 67(2):198-201. PubMed ID: 20338708 [TBL] [Abstract][Full Text] [Related]
9. Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil. Balassiano IT; Miranda KR; Boente RF; Pauer H; Oliveira IC; Santos-Filho J; Amorim EL; Caniné GA; Souza CF; Gomes MZ; Ferreira EO; Brazier JS; Domingues RM Anaerobe; 2009 Jun; 15(3):61-4. PubMed ID: 19154793 [TBL] [Abstract][Full Text] [Related]
10. [Clostridium difficile ribotype 027, toxinotype III in The Netherlands]. Kuijper EJ; Debast SB; Van Kregten E; Vaessen N; Notermans DW; van den Broek PJ Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2087-9. PubMed ID: 16201596 [TBL] [Abstract][Full Text] [Related]
11. Isolation of Clostridium difficile ribotype 027, toxinotype III in the Netherlands after increase in C. difficile-associated diarrhoea. van Steenbergen J; Debast S; van Kregten E; van den Berg R; Notermans D; Kuijper E Euro Surveill; 2005 Jul; 10(7):E050714.1. PubMed ID: 16785657 [No Abstract] [Full Text] [Related]
12. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada. MacCannell DR; Louie TJ; Gregson DB; Laverdiere M; Labbe AC; Laing F; Henwick S J Clin Microbiol; 2006 Jun; 44(6):2147-52. PubMed ID: 16757612 [TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors. Sundram F; Guyot A; Carboo I; Green S; Lilaonitkul M; Scourfield A J Hosp Infect; 2009 Jun; 72(2):111-8. PubMed ID: 19386381 [TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile ribotype 027 is not evenly distributed in Hesse, Germany. Arvand M; Bettge-Weller G Anaerobe; 2016 Aug; 40():1-4. PubMed ID: 27063988 [TBL] [Abstract][Full Text] [Related]
15. Comparison of molecular typing methods applied to Clostridium difficile. Kuijper EJ; van den Berg RJ; Brazier JS Methods Mol Biol; 2009; 551():159-71. PubMed ID: 19521874 [TBL] [Abstract][Full Text] [Related]
16. Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain. Huang H; Weintraub A; Fang H; Nord CE Scand J Infect Dis; 2009; 41(2):158-9. PubMed ID: 18846478 [No Abstract] [Full Text] [Related]
17. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007]. Poilane I; Fantinato C; Cruaud P; Collignon A Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360 [TBL] [Abstract][Full Text] [Related]
18. Molecular and clinical characteristics of Clostridium difficile infection in a University Hospital in Shanghai, China. Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE Clin Infect Dis; 2008 Dec; 47(12):1606-8. PubMed ID: 19025371 [No Abstract] [Full Text] [Related]
19. What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Dumford DM; Nerandzic MM; Eckstein BC; Donskey CJ Am J Infect Control; 2009 Feb; 37(1):15-9. PubMed ID: 19171247 [TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes. Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]